Parexel and Palantir Forge Deeper Partnership to Enhance Clinical Trials with AI

This collaboration sees Parexel integrating Palantir's Foundry and Artificial Intelligence Platform (AIP) into its clinical data platform, marking a significant leap forward in leveraging cutting-edge technology to enhance trial execution.
Parexel and Palantir Technologies have unveiled an ambitious multi-year strategic partnership aimed at harnessing the power of artificial intelligence (AI) to elevate the delivery of clinical trials for Parexel's clientele. This collaboration sees Parexel integrating Palantir's Foundry and Artificial Intelligence Platform (AIP) into its clinical data platform, marking a significant leap forward in leveraging cutting-edge technology to enhance trial execution. Elevating Clinical Trial Execution with AI The partnership centers on enhancing Parexel's Precision Pathway, an end-to-end operational strategy that prioritizes the utilization of clean data in clinical trials. By leveraging Palantir's software, Precision Pathway will create an integrated digital environment to automate manual p
Subscribe or log in to Continue Reading

Uncompromising innovation. Timeless influence. Your support powers the future of independent tech journalism.

Already have an account? Sign In.

📣 Want to advertise in AIM Research? Book here >

Picture of Anshika Mathews
Anshika Mathews
Anshika is the Senior Content Strategist for AIM Research. She holds a keen interest in technology and related policy-making and its impact on society. She can be reached at anshika.mathews@aimresearch.co
25 July 2025 | 583 Park Avenue, New York
The Biggest Exclusive Gathering of CDOs & AI Leaders In United States

Subscribe to our Newsletter: AIM Research’s most stimulating intellectual contributions on matters molding the future of AI and Data.